Rocket Lab's Iridium Calculus: Why a Rival's FCC Filing Hits the Share Price Harder Than It Should

Rocket Lab shares fell 4.1% Friday, 11% weekly, after SpaceX urged FCC scrutiny of Iridium deal; business records Q2 revenue $234M, backlog $2.36B.

The curious thing about Rocket Lab's recent share slide is that it has almost nothing to do with the company itself. A rival's regulatory complaint, a deal structured around a floating exchange ratio, and a stock price caught in the feedback loop between the two — that is the real story behind Friday's 4.1 percent drop and the 11 percent weekly decline.

SpaceX has asked the Federal Communications Commission to scrutinize Iridium's conduct while the agency weighs Rocket Lab's acquisition application. Matthew Turk, a satellite policy staffer at SpaceX, accused Iridium of a "well-documented history of anticompetitive attacks" hanging over the proposed transaction. The sector-wide sell-off that followed rippled through launch and space systems providers, with Rocket Lab absorbing the hit despite no company-specific catalyst.

The Structural Reason the Market Flinched

What makes this regulatory noise so potent for Rocket Lab specifically is the deal's architecture. The payout to Iridium shareholders is tied to a variable exchange ratio based on Rocket Lab's volume-weighted ten-day average stock price near closing. That creates a self-reinforcing loop: regulatory uncertainty pushes the stock down, which implicitly worsens the valuation math for the counterparty. It is a mechanical feedback effect that tends to get underestimated until it is already in motion.

The antitrust hurdle in the US, notably, has already been cleared — the Hart-Scott-Rodino waiting period expired on August 12. Rocket Lab has also filed an S-4 registration statement with the SEC to register the shares earmarked as purchase consideration. The SpaceX intervention thus looks less like a fundamental deal-breaker and more like a targeted jab timed just ahead of the September 24 shareholder vote on the merger.

Operations Tell a Different Story

While the stock stumbles, the underlying business keeps setting records. Second-quarter 2026 revenue hit $234 million, up 62 percent year over year, with a backlog of $2.36 billion — more than double the prior-year figure. The company guides to $250–265 million in revenue for the third quarter, supported by fresh US Space Force awards totaling $397 million for the SB-AMTI program and a $12 million contract for an optical space communications consortium.

August brought the 93rd Electron launch, the 14th mission of the year, delivering the ninth iQPS Earth-observation satellite with a claimed 100 percent success rate. Days earlier, eight satellite platforms for MDA Space reached orbit — the first batch of a 17-platform constellation under a $143 million Globalstar direct-communication contract. The defense pipeline has deepened too: Rocket Lab joined the Space Data Network Consortium and secured two delivery orders worth $12 million combined for secure optical communications under the SDN-B program.

Yet the GAAP net loss stands at $49.3 million. Growth and losses run in parallel here more starkly than at nearly any comparable company.

The Insider Signal

Five executives sold shares on August 27 totaling $5.49 million, including COO Frank Klein's tranche of roughly $3.18 million. Formally, these were sell-to-cover transactions to settle tax obligations from vested restricted stock units, not discretionary profit-taking. But in a period of heightened price sensitivity, the clustering of insider sales adds a layer of noise that is hard to dismiss entirely.

Neutron Remains the Real Watch Item

Beyond Iridium and the defense contracts, the pivotal variable for investors is a piece of hardware: Neutron's reusable fairing, internally nicknamed "Hungry Hippo." Test runs under flight-like conditions continue, but the window for delivering the rocket to the pad in the fourth quarter of 2026 is narrowing. CFO Adam Spice has suggested that a successful Neutron test flight could push the company into positive adjusted operating territory as soon as the following quarter — a reminder of how much weight rests on this single vehicle.

The stock trades at €55.60, roughly 58 percent below its 52-week high of €133.80 but still 71 percent above its yearly low of €32.60. With an RSI of 34.8, the shares sit near oversold territory, suggesting much of the regulatory anxiety is already priced in. Until the September 24 vote, though, volatility is the likelier default: every fresh signal from the FCC will translate directly into the share price, and the gap between a record-setting business and a fragile, stock-price-linked acquisition process leaves Rocket Lab in an uncomfortable orbit.